Subscribe to RSS
DOI: 10.1055/s-0035-1569067
Safety of Salvaged Blood and Risk of Coagulopathy in Cardiac Surgery
Publication History
Publication Date:
02 February 2016 (online)
Abstract
Cardiac surgery patients are prone to anemia from several mechanisms: intraoperative blood loss, preexisting anemia, and hemodilution. Patients are very frequently transfused with allogeneic red blood cells (RBC), which in itself is associated with harm. The use of RBC salvage technology has been advocated to salvage blood lost in the operative field and to reduce the need of homologous blood transfusion. Direct cardiotomy suction from the surgical field and unprocessed blood retransfusion is a common practice during cardiopulmonary bypass, but which is associated with a powerful activation of the coagulation and inflammatory systems: thrombin generation, excessive fibrinolysis, and release of proinflammatory cytokines. Compared with direct cardiotomy suction, the use of RBC salvage technology is able to reduce the amount of microparticles and activated proteins of autologous blood before retransfusion. However, when compared with no retransfusion of blood from the operative field, processed blood also triggers coagulopathy and inflammation. Clinical studies are discordant regarding the benefit of RBC salvage use during and after cardiac operations. Meta-analysis suggests reduced need of homologous blood transfusion, but no effects on mortality and morbidity.
-
References
- 1 Hare GM, Freedman J, David Mazer C. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety?. Can J Anaesth 2013; 60 (2) 168-175
- 2 Wilkerson DK, Rosen AL, Sehgal LR, Gould SA, Sehgal HL, Moss GS. Limits of cardiac compensation in anemic baboons. Surgery 1988; 103 (6) 665-670
- 3 Jan KM, Chien S. Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. Am J Physiol 1977; 233 (1) H106-H113
- 4 Loor G, Koch CG, Sabik III JF, Li L, Blackstone EH. Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardiovasc Surg 2012; 144 (3) 538-546
- 5 Andreasen JJ, Westen M, Pallesen PA, Jensen S, Gorst-Rasmussen A, Johnsen SP. Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit. Interact Cardiovasc Thorac Surg 2007; 6 (5) 623-627
- 6 Stover EP, Siegel LC, Parks R , et al; Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Anesthesiology 1998; 88 (2) 327-333
- 7 Loor G, Rajeswaran J, Li L , et al. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 2013; 146 (6) 1480-1487.e6
- 8 Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005; 105 (6) 2266-2273
- 9 Surgenor SD, Kramer RS, Olmstead EM , et al; Northern New England Cardiovascular Disease Study Group. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108 (6) 1741-1746
- 10 Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116 (22) 2544-2552
- 11 Surgenor SD, DeFoe GR, Fillinger MP , et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006; 114 (1, Suppl): I43-I48
- 12 Hillis LD, Smith PK, Anderson JL , et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Cardiovascular Anesthesiologists; Society of Thoracic Surgeons. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58 (24) e123-e210
- 13 Belway D, Rubens FD, Wozny D, Henley B, Nathan HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion 2005; 20 (5) 237-241
- 14 Schmidt H, Lund JO, Nielsen SL. Autotransfused shed mediastinal blood has normal erythrocyte survival. Ann Thorac Surg 1996; 62 (1) 105-108
- 15 Ansell J, Parrilla N, King M , et al. Survival of autotransfused red blood cells recovered from the surgical field during cardiovascular operations. J Thorac Cardiovasc Surg 1982; 84 (3) 387-391
- 16 Wixson RL, Kwaan HC, Spies SM, Zimmer AM. Reinfusion of postoperative wound drainage in total joint arthroplasty. Red blood cell survival and coagulopathy risk. J Arthroplasty 1994; 9 (4) 351-358
- 17 de Haan J, Boonstra PW, Monnink SH, Ebels T, van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995; 59 (4) 901-907
- 18 Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?. Thromb Haemost 1993; 70 (2) 259-262
- 19 Paparella D, Galeone A, Venneri MT , et al. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2006; 131 (2) 290-297
- 20 Parolari A, Colli S, Mussoni L , et al. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery. J Thorac Cardiovasc Surg 2003; 125 (2) 336-343
- 21 Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds Jr LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93 (11) 2014-2018
- 22 Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21 (2) 232-244
- 23 Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004; 78 (1) 54-59
- 24 Skrabal CA, Khosravi A, Choi YH , et al. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Scand Cardiovasc J 2006; 40: 219-223
- 25 Amand T, Pincemail J, Blaffart F, Larbuisson R, Limet R, Defraigne JO. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 2002; 17 (2) 117-123
- 26 Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbrüchel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Ann Thorac Surg 2010; 89 (5) 1511-1517
- 27 Aldea GS, Soltow LO, Chandler WL , et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002; 123 (4) 742-755
- 28 Walpoth BH, Eggensperger N, Hauser SP , et al. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery. Int J Artif Organs 1999; 22 (4) 210-216
- 29 Allen SJ, McBride WT, McMurray TJ , et al. Cell salvage alters the systemic inflammatory response after off-pump coronary artery bypass grafting surgery. Ann Thorac Surg 2007; 83 (2) 578-585
- 30 Jewell AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg 2003; 23 (4) 633-636
- 31 Takayama H, Soltow LO, Aldea GS. Differential expression in markers for thrombin, platelet activation, and inflammation in cell saver versus systemic blood in patients undergoing on-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2007; 21 (4) 519-523
- 32 Scrascia G, Rotunno C, Nanna D , et al. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion 2012; 27 (4) 270-277
- 33 Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ ; Cardiotomy Investigators. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 2007; 116 (11, Suppl) I89-I97
- 34 Djaiani G, Fedorko L, Borger MA , et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 2007; 116 (17) 1888-1895
- 35 Klein AA, Nashef SA, Sharples L , et al. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesth Analg 2008; 107 (5) 1487-1495
- 36 Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion 2003; 18 (2) 115-121
- 37 Whitlock R, Mathew J, Eikelboom J, Al-Saleh AM, Yuan F, Teoh K. Processed residual pump blood in cardiac surgery: the Processed Residual Blood in Cardiac surgery trial. Transfusion 2013; 53 (7) 1487-1492
- 38 Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109 (2) 320-330
- 39 Paparella D, Scrascia G, Rotunno C , et al. A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial. J Cardiothorac Vasc Anesth 2012; 26 (4) 557-562